SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Nov. 21, 2023 /PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company specializing in innovative treatments for prostate cancer, will be participating in the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, in New York. The presentation will take place at 12:00 p.m. ET.
During the conference, David R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will be hosting one-on-one meetings and presenting on behalf of ESSA. These key executives will provide unique insights into the Company’s advancements in prostate cancer treatment.
For those unable to attend the event in person, a live webcast of the presentation will be available on ESSA’s website, www.essapharma.com, in the Investors/Events & Presentations section. The webcast will offer an opportunity for investors, analysts, and stakeholders to gain further understanding of ESSA’s pipeline and its potential impact on the treatment landscape of prostate cancer. Following the conference, the webcast will be stored on the ESSA website for a period of 90 days, allowing individuals to access the information at their convenience.
About ESSA Pharma Inc.
ESSA Pharma Inc. is a renowned clinical-stage biopharmaceutical company focused on developing groundbreaking and exclusive therapies for patients diagnosed with prostate cancer. With a commitment to innovation and patient-centricity, ESSA aims to revolutionize the treatment options available for prostate cancer, ultimately improving patient outcomes and quality of life. To learn more about ESSA Pharma and its pioneering work, please visit www.essapharma.com. Stay up-to-date with the latest news and developments by following ESSA on Twitter and LinkedIn.
FAQ
1. What is ESSA Pharma known for?
ESSA Pharma is a clinical-stage pharmaceutical company specializing in the development of novel therapies for the treatment of prostate cancer.
2. What conference will ESSA Pharma be presenting at?
ESSA Pharma will be participating in the Piper Sandler 35th Annual Healthcare Conference.
3. Who will be presenting on behalf of ESSA Pharma?
David R. Parkinson, President, and Chief Executive Officer; Peter Virsik, Chief Operating Officer; and David S. Wood, Chief Financial Officer, will be hosting one-on-one meetings and presenting at the conference.
4. How can I access the presentation if I cannot attend in person?
A live webcast of the presentation will be available on ESSA’s website, www.essapharma.com, in the Investors/Events & Presentations section. The webcast will also be archived on the ESSA website for 90 days following the event.